Vanguard Group’s Processa Pharmaceuticals PCSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.01K | Hold |
24,433
| – | – | ﹤0.01% | 4266 |
|
|
2025
Q1 | $9.04K | Hold |
24,433
| – | – | ﹤0.01% | 4258 |
|
|
2024
Q4 | $21.7K | Hold |
24,433
| – | – | ﹤0.01% | 4256 |
|
|
2024
Q3 | $33.5K | Hold |
24,433
| – | – | ﹤0.01% | 4272 |
|
|
2024
Q2 | $54.7K | Hold |
24,433
| – | – | ﹤0.01% | 4283 |
|
|
2024
Q1 | $57.8K | Sell |
24,433
-210,220
| -90% | -$497K | ﹤0.01% | 4303 |
|
|
2023
Q4 | $78.5K | Sell |
234,653
-109,772
| -32% | -$36.7K | ﹤0.01% | 4327 |
|
|
2023
Q3 | $86.2K | Sell |
344,425
-17,254
| -5% | -$4.32K | ﹤0.01% | 4361 |
|
|
2023
Q2 | $180K | Hold |
361,679
| – | – | ﹤0.01% | 4325 |
|
|
2023
Q1 | $181K | Sell |
361,679
-12,148
| -3% | -$6.08K | ﹤0.01% | 4333 |
|
|
2022
Q4 | $411K | Buy |
373,827
+129
| +0% | +$142 | ﹤0.01% | 4155 |
|
|
2022
Q3 | $845K | Buy |
373,698
+100
| +0% | +$226 | ﹤0.01% | 4055 |
|
|
2022
Q2 | $1.05M | Hold |
373,598
| – | – | ﹤0.01% | 4071 |
|
|
2022
Q1 | $1.13M | Hold |
373,598
| – | – | ﹤0.01% | 4169 |
|
|
2021
Q4 | $1.83M | Sell |
373,598
-293
| -0.1% | -$1.44K | ﹤0.01% | 4077 |
|
|
2021
Q3 | $3.2M | Buy |
373,891
+720
| +0.2% | +$6.17K | ﹤0.01% | 3889 |
|
|
2021
Q2 | $3.06M | Buy |
373,171
+215,532
| +137% | +$1.77M | ﹤0.01% | 3829 |
|
|
2021
Q1 | $1.72M | Buy |
157,639
+129,017
| +451% | +$1.41M | ﹤0.01% | 3898 |
|
|
2020
Q4 | $189K | Buy |
+28,622
| New | +$189K | ﹤0.01% | 4093 |
|